TCL Archive NCI Proposes New Grants and Centers For Molecular Target-Based Therapeutics March 26, 1999
TCL Archive Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer June 5, 2009
TCL Archive NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study. June 3, 2005